Bone-Density Drug Could Lower Colorectal Cancer Risk

Israeli and American researchers reported this week in the Journal of Clinical Oncology on a new study suggesting that postmenopausal women taking alendronate (Fosamax) were less likely to develop colorectal cancer. The results are “intriguing,” said Eric Jacobs, the American…  Read More